Merck KGaA management won't use mass firings to reduce its 11,000-employee workforce in Germany to cut costs, Die Welt said, citing a company document. But it is unclear what strategy will be used for employees outside the country. Report
| Tuesday April 28th | 11am ET / 8am PT | Sponsored by: Parexel
This webinar will summarize the core scientific concepts needed to develop a global observational study protocol that describes or evaluates a therapeutic treatment in patients under conditions of usual care, in terms of clinical, humanistic and economic outcomes for a variety of key stakeholders. Register Today!
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!